MULLEN JAMES C
SEC CIK 1226288 · EDGAR
BoughtSold
Most active insiders at TMO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | CASPER MARC N | COB, CEO, Dir | — | $53.89M |
| 2 | Lagarde Michel | EVP, COO | — | $51.31M |
| 3 | Shafer Michael D | EVP | — | $22.54M |
| 4 | Britt Lisa P. | SVP, Chief HR Off | — | $16.87M |
| 5 | Lowery Frederick M. | EVP | — | $8.15M |
| 6 | Pettiti Gianluca | Pres, COO | — | $5.12M |
| 7 | Holmes Joseph R. | VP, CAO | — | $245.6K |
| 8 | Meyer James | CFO, Sr. VP | — | — |
| 9 | Shropshire Thomas B Jr. | SVP, GC | — | — |
| 10 | Keith R. Alexandra | Dir | — | — |
MULLEN JAMES C made no open-market trades at TMO in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-22 | 2025-05-21 | TMO | Thermo Fisher Scientific | MULLEN JAMES C | Dir | A - Grant | $0.00 | +565 | 3,393 | +20% | $0 | |
| 2024-05-23 | 2024-05-22 | TMO | Thermo Fisher Scientific | MULLEN JAMES C | Dir | A - Grant | $0.00 | +339 | 2,828 | +14% | $0 | |
| 2023-05-26 | 2023-05-24 | TMO | Thermo Fisher Scientific | MULLEN JAMES C | Dir | A - Grant | $0.00 | +392 | 2,489 | +19% | $0 | |
| 2022-05-20 | 2022-05-18 | TMO | Thermo Fisher Scientific | MULLEN JAMES C | Dir | A - Grant | $0.00 | +369 | 2,097 | +21% | $0 | |
| 2022-01-04 | 2022-01-03 | EDIT | Editas Medicine, Inc. | MULLEN JAMES C | CEO, Dir | S - Sale | $26.95 | -18.3K | 75.9K | -19% | -$491.9K | |
| 2021-12-23 | 2021-12-22 | EDIT | Editas Medicine, Inc. | MULLEN JAMES C | CEO, Dir | A - Grant | $0.00 | +36.5K | 94.2K | +63% | $0 | |
| 2021-10-20 | 2021-10-18 | EDIT | Editas Medicine, Inc. | MULLEN JAMES C | CEO, Dir | S - Sale | $38.03 | -13.8K | 57.7K | -19% | -$525.0K | |
| 2021-10-04 | 2021-09-30 | EDIT | Editas Medicine, Inc. | MULLEN JAMES C | CEO, Dir | A - Grant | $0.00 | +36.5K | 71.5K | +104% | $0 |
Purchase Sale Sale after option exercise All abbreviations